Epizyme, Inc. 4
4 · Epizyme, Inc. · Filed Aug 19, 2014
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
Hedrick Eric
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2014-08-15−2,000→ 280,500 totalExercise: $2.19Exp: 2022-06-06→ Common Stock (2,000 underlying) - Sale
Common Stock, par value $0.0001 per share
2014-08-15$38.60/sh−2,000$77,200→ 0 total - Exercise/Conversion
Common Stock, par value $0.0001 per share
2014-08-15$2.19/sh+2,000$4,380→ 2,000 total
Footnotes (2)
- [F1]The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]This option was granted on June 7, 2012 with respect to 300,000 shares of Common Stock, with 25% vesting on May 8, 2013 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.